Endosomal Escape of Polymer-Coated Silica Nanoparticles in Endothelial Cells.


Journal

Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338

Informations de publication

Date de publication:
09 2020
Historique:
received: 31 12 2019
revised: 07 06 2020
pubmed: 10 7 2020
medline: 18 5 2021
entrez: 10 7 2020
Statut: ppublish

Résumé

Current investigations into hazardous nanoparticles (i.e., nanotoxicology) aim to understand the working mechanisms that drive toxicity. This understanding has been used to predict the biological impact of the nanocarriers as a function of their synthesis, material composition, and physicochemical characteristics. It is particularly critical to characterize the events that immediately follow cell stress resulting from nanoparticle internalization. While reactive oxygen species and activation of autophagy are universally recognized as mechanisms of nanotoxicity, the progression of these phenomena during cell recovery has yet to be comprehensively evaluated. Herein, primary human endothelial cells are exposed to controlled concentrations of polymer-functionalized silica nanoparticles to induce lysosomal damage and achieve cytosolic delivery. In this model, the recovery of cell functions lost following endosomal escape is primarily represented by changes in cell distribution and the subsequent partitioning of particles into dividing cells. Furthermore, multilamellar bodies are found to accumulate around the particles, demonstrating progressive endosomal escape. This work provides a set of biological parameters that can be used to assess cell stress related to nanoparticle exposure and the subsequent recovery of cell processes as a function of endosomal escape.

Identifiants

pubmed: 32643290
doi: 10.1002/smll.201907693
doi:

Substances chimiques

Polymers 0
Silicon Dioxide 7631-86-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1907693

Informations de copyright

© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

B. Fadeel, L. Farcal, B. Hardy, S. Vázquez-Campos, D. Hristozov, A. Marcomini, I. Lynch, E. Valsami-Jones, H. Alenius, K. Savolainen, Nat. Nanotechnol. 2018, 13, 537.
O. Maimon, A. Browarnik, NHECD. Tel Aviv University, Department of Industrial Engineering, Israel 2008.
S. T. Stern, P. P. Adiseshaiah, R. M. Crist, Part. Fibre Toxicol. 2012, 9, 20.
R. Tanguay, Challenges and Advances in Nanotoxicology, Multidisciplinary Digital Publishing Institute, Nanomaterials (Basel) 2014, pp. 766-767.
H. L. Herd, K. T. Bartlett, J. A. Gustafson, L. D. McGill, H. Ghandehari, Biomaterials 2015, 53, 574.
R. C. Murdock, L. Braydich-Stolle, A. M. Schrand, J. J. Schlager, S. M. Hussain, Toxicol. Sci. 2008, 101, 239.
P. P. Fu, Q. Xia, H.-M. Hwang, P. C. Ray, H. Yu, J. Food Drug Anal. 2014, 22, 64.
S. Z. Khaled, A. Cevenini, I. K. Yazdi, A. Parodi, M. Evangelopoulos, C. Corbo, S. Scaria, Y. Hu, S. G. Haddix, B. Corradetti, Biomaterials 2016, 87, 57.
R. Kircheis, L. Wightman, E. Wagner, Adv. Drug Delivery Rev. 2001, 53, 341.
J.-P. Behr, CHIMIA Int. J. Chem. 1997, 51, 34.
O. Boussif, F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, J. P. Behr, Proc. Natl. Acad. Sci. USA 1995, 92, 7297.
J. O. Martinez, A. Parodi, X. Liu, M. G. Kolonin, M. Ferrari, E. Tasciotti, Small 2013, 9, 1696.
V. Francia, A. Aliyandi, A. Salvati, Nanoscale 2018, 10, 16645.
Y. Cao, Y. Gong, L. Liu, Y. Zhou, X. Fang, C. Zhang, Y. Li, J. Li, J. Appl. Toxicol. 2017, 37, 1359.
A. Parodi, N. Quattrocchi, A. L. Van De Ven, C. Chiappini, M. Evangelopoulos, J. O. Martinez, B. S. Brown, S. Z. Khaled, I. K. Yazdi, M. V. Enzo, Nat. Nanotechnol. 2013, 8, 61.
J. O. Martinez, M. Evangelopoulos, V. Karun, E. Shegog, J. A. Wang, C. Boada, X. Liu, M. Ferrari, E. Tasciotti, Biomaterials 2014, 35, 9824.
J. W. Myerson, A. C. Anselmo, Y. Liu, S. Mitragotri, D. M. Eckmann, V. R. Muzykantov, Adv. Drug Delivery Rev. 2016, 99, 97.
A. Albini, V. Mussi, A. Parodi, A. Ventura, E. Principi, S. Tegami, M. Rocchia, E. Francheschi, I. Sogno, R. Cammarota, Nanomedicine 2010, 6, 277.
M. Wojnilowicz, A. Glab, A. Bertucci, F. Caruso, F. Cavalieri, ACS Nano 2019, 13, 187.
N. Symens, S. J. Soenen, J. Rejman, K. Braeckmans, S. C. De Smedt, K. Remaut, Adv. Drug Delivery Rev. 2012, 64, 78.
P. Walczak, D. A. Kedziorek, A. A. Gilad, B. P. Barnett, J. W. Bulte, Magn. Reson. Med. 2007, 58, 261.
M. Rudzinska, A. Parodi, A. V. Balakireva, O. E. Chepikova, F. M. Venanzi, A. A. Zamyatnin Jr., Antioxidants 2020, 9, 94.
D. L. Moore, S. Jessberger, Trends Cell Biol. 2017, 27, 82.
L. Sun, Y. Li, X. Liu, M. Jin, L. Zhang, Z. Du, C. Guo, P. Huang, Z. Sun, Toxicol. In Vitro 2011, 25, 1619.
J. Duan, Y. Yu, Y. Yu, Y. Li, P. Huang, X. Zhou, S. Peng, Z. Sun, Part. Fibre Toxicol. 2014, 11, 50.
J. Wang, Y. Yu, K. Lu, M. Yang, Y. Li, X. Zhou, Z. Sun, Int. J. Nanomed. 2017, 12, 809.
Y. Nishida, S. Arakawa, K. Fujitani, H. Yamaguchi, T. Mizuta, T. Kanaseki, M. Komatsu, K. Otsu, Y. Tsujimoto, S. Shimizu, Nature 2009, 461, 654.
L. I. Selby, C. M. Cortez-Jugo, G. K. Such, A. P. Johnston, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2017, 9, e1452.
M. G. Bexiga, J. A. Varela, F. Wang, F. Fenaroli, A. Salvati, I. Lynch, J. C. Simpson, K. A. Dawson, Nanotoxicology 2011, 5, 557.
M. Hariri, G. Millane, M. P. Guimond, G. Guay, J. W. Dennis, I. R. Nabi, Mol. Biol. Cell 2000, 11, 255.
M. Borkowska, M. Siek, D. V. Kolygina, Y. I. Sobolev, S. Lach, S. Kumar, Y. K. Cho, K. Kandere-Grzybowska, B. A. Grzybowski, Nat. Nanotechnol. 2020, 15, 331.
J. O. Martinez, M. Evangelopoulos, C. Chiappini, X. Liu, M. Ferrari, E. Tasciotti, J. Biomed. Mater. Res. A 2014, 102, 3540.
J. O. Martinez, C. Boada, I. K. Yazdi, M. Evangelopoulos, B. S. Brown, X. Liu, M. Ferrari, E. Tasciotti, Small 2013, 9, 1722.
J. O. Martinez, M. Evangelopoulos, R. Bhavane, S. Acciardo, F. Salvatore, X. Liu, M. Ferrari, E. Tasciotti, Curr. Drug Targets 2015, 16, 1582.
I. K. Yazdi, A. Ziemys, M. Evangelopoulos, J. O. Martinez, M. Kojic, E. Tasciotti, Nanomedicine 2015, 10, 3057.
M. Hofmann-Amtenbrink, D. W. Grainger, H. Hofmann, Nanomedicine 2015, 11, 1689.
S. Nakki, J. O. Martinez, M. Evangelopoulos, W. Xu, V. P. Lehto, E. Tasciotti, ACS Appl. Mater. Interfaces 2017, 9, 23441.
M. Evangelopoulos, E. Tasciotti, Nanomedicine 2017, 12, 5.
R. Palomba, A. Parodi, M. Evangelopoulos, S. Acciardo, C. Corbo, E. de Rosa, I. K. Yazdi, S. Scaria, R. Molinaro, N. E. Furman, J. You, M. Ferrari, F. Salvatore, E. Tasciotti, Sci. Rep. 2016, 6, 34422.
M. Evangelopoulos, A. Parodi, J. O. Martinez, I. K. Yazdi, A. Cevenini, A. L. van de Ven, N. Quattrocchi, C. Boada, N. Taghipour, C. Corbo, B. S. Brown, S. Scaria, X. Liu, M. Ferrari, E. Tasciotti, Biomaterials 2016, 82, 168.
M. Evangelopoulos, I. K. Yazdi, S. Acciardo, R. Palomba, F. Giordano, A. Pasto, M. Sushnitha, J. O. Martinez, N. Basu, A. Torres, S. Hmaidan, A. Parodi, E. Tasciotti, Sci. Rep. 2020, 10, 172.
J. A. Hubbell, R. Langer, Nat. Mater. 2013, 12, 963.
R. J. Riddell, R. H. Clothier, M. Balls, Food Chem. Toxicol. 1986, 24, 469.
S. Spaziani, E. Imperlini, A. Mancini, M. Caterino, P. Buono, S. Orru, Proteomics 2014, 14, 1623.

Auteurs

Alessandro Parodi (A)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.
Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia.

Michael Evangelopoulos (M)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Noemi Arrighetti (N)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.
Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, 20133, Italy.

Armando Cevenini (A)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.
Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, 80131, Italy.
CEINGE-Biotecnologie Avanzate S.C.R.L., Napoli, NA 80145, Italy.

Megan Livingston (M)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Sm Z Khaled (SZ)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Brandon S Brown (BS)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Iman K Yazdi (IK)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Francesca Paradiso (F)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Jocelyn N Campa-Carranza (JN)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Alessandro De Vita (A)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, 47014, Italy.

Francesca Taraballi (F)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Ennio Tasciotti (E)

Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH